| Product NDC: | 54473-080 |
| Proprietary Name: | CounterAct |
| Non Proprietary Name: | Dextromethorphan HBr. and Guaifenesin |
| Active Ingredient(s): | 10; 100 mg/5mL; mg/5mL & nbsp; Dextromethorphan HBr. and Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54473-080 |
| Labeler Name: | Melaleuca, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20090828 |
| Package NDC: | 54473-080-04 |
| Package Description: | 1 BOTTLE in 1 BOX (54473-080-04) > 118 mL in 1 BOTTLE |
| NDC Code | 54473-080-04 |
| Proprietary Name | CounterAct |
| Package Description | 1 BOTTLE in 1 BOX (54473-080-04) > 118 mL in 1 BOTTLE |
| Product NDC | 54473-080 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dextromethorphan HBr. and Guaifenesin |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20090828 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Melaleuca, Inc. |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Strength Number | 10; 100 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |